EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, IDEXX Laboratories's enterprise value is $41,363 Mil.
IDEXX Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $3,661 Mil. Therefore, IDEXX Laboratories's EV-to-Revenue for today is 11.30.
The historical rank and industry rank for IDEXX Laboratories's EV-to-Revenue or its related term are showing as below:
IDXX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.54 Med: 8.99 Max: 19.99
Current: 11.3
During the past 13 years, the highest EV-to-Revenue of IDEXX Laboratories was 19.99. The lowest was 3.54. And the median was 8.99.
IDXX's EV-to-Revenue is ranked worse than 85.09% of 228
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.045
vs IDXX: 11.30
As of today (2024-04-16), IDEXX Laboratories's stock price is $492.325.
IDEXX Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $43.60. Therefore, IDEXX Laboratories's PS Ratio for today is 11.29.
IDEXX Laboratories EV-to-Revenue Historical Data
The historical data trend for IDEXX Laboratories's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
IDEXX Laboratories Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
9.68
16.01
17.59
10.45
12.76
IDEXX Laboratories Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
10.45
12.45
12.16
10.35
12.76
Competitive Comparison
For the Diagnostics & Research subindustry, IDEXX Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories EV-to-Revenue Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's EV-to-Revenue falls into.
IDEXX Laboratories's current Enterprise Value is $41,363 Mil.
IDEXX Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,661 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories's share price for today is $492.325.
IDEXX Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $43.60.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of IDEXX Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
IDEXX Laboratories (IDEXX Laboratories) Business Description
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IDXX has been successfully added to your 